CRISIL reaffirms AA/ stable rating to Ipca Laboratories’ bank facilities

05 Sep 2013 Evaluate

Credit rating agency, CRISIL has reaffirmed AA/ stable rating to Ipca Laboratories’ long term bank facilities. The rating agency has also reaffirmed AA/ stable rating to the company’s Rs 20.00 crore Non Convertible Debentures (NCDs) and 50.00 crore Non Convertible Debentures (NCDs) .Total bank long facilities Rs 1182.50 crore

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1590.55 17.35 (1.10%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.